Stealth BioTherapeutics Enters Going Private Agreement

Stealth BioTherapeutics Corp (NASDAQ:MITO) will be acquired by a consortium of investors led by Morningside Venture (I) Investments Ltd and J.…
  • Stealth BioTherapeutics Corp (NASDAQ:MITO) will be acquired by a consortium of investors led by Morningside Venture (I) Investments Ltd and J. Wood Capital Advisors LLC in an all-cash transaction. 
  • Each Stealth Bio will be canceled and cease to exist for the right to receive $0.03125 in cash. Each American Depositary Share representing 12 shares will be canceled for the right to receive $0.375.
  • Related: Stealth Bio Shares Trading Higher On Pre-Clinical Presentation Of Neuromuscular Disease Candidate.
  • The merger consideration represents a premium of 34.4% to the closing price on June 24, the last trading day before the company announced its receipt of the original “going-private” proposal.
  • The merger is expected to close during the second half of 2022.
  • Price Action: MITO shares are up 19.6% at $0.29 during the market session on the last check Monday.
Total
0
Shares
Related Posts
Read More

Ribbon Communications And 2 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones jumped more than 500 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CRKR